Acceder Registro /

Pedro Jiménez Guerrero

Buscador

García-Serna AM, Hernández-Caselles T, Jiménez-Guerrero P, Martín-Orozco E, Pérez-Fernández V, Cantero-Cano E, Muñoz-García M, Ballesteros-Meseguer C, Pérez de Los Cobos I, García-Marcos L, Morales E; NELA Study group. Air pollution from traffic during pregnancy impairs newborn's cord blood immune cells: The NELA cohort. Environ Res. 2021 Jul;198:110468. doi: 10.1016/j.envres.2020.110468. Epub 2020 Nov 17. PubMed PMID: 33217431.
AÑO: 2021; IF: 8.431
Sola-Martínez RA, Lozano-Terol G, Gallego-Jara J, Morales E, Cantero-Cano E, Sanchez-Solis M, García-Marcos L, Jiménez-Guerrero P, Noguera-Velasco JA, Cánovas Díaz M, de Diego Puente T; NELA study group. Exhaled volatilome analysis as a useful tool to discriminate asthma with other coexisting atopic diseases in women of childbearing age. Sci Rep. 2021 Jul 5;11(1):13823. doi: 10.1038/s41598-021-92933-2. PubMed PMID: 34226570; PubMed Central PMCID: PMC8257728.
AÑO: 2021; IF: 4.996
Morales E, Alcantara-Lopez MV, Cabezas-Herrera J, de Diego T, Hernandez-Caselles T, Jimenez-Guerrero P, Larque E, Lopez-Soler C, Martinez-Gracia C, Martinez-Torres A, Martin-Orozco E, Mendiola J, Nieto-Díaz A, Noguera JA, Perez-Fernandez V, Prieto-Sánchez MT, Salvador-Garcia C, Sanchez-Solis M, Santaella-Pascual M, Sola-Martinez RA, Torres-Cantero A, Yagüe-Guirao G, Zornoza-Moreno M, Garcia-Marcos L; NELA Study Group. The Nutrition in Early Life and Asthma (NELA) birth cohort study: Rationale, design, and methods. Paediatr Perinat Epidemiol. 2022 Mar;36(2):310-324. doi: 10.1111/ppe.12826. Epub 2021 Nov 28. PubMed PMID: 34841558.
AÑO: 2022; IF: 2.8
García-Serna AM, Martín-Orozco E, Jiménez-Guerrero P, Hernández-Caselles T, Pérez-Fernández V, Cantero-Cano E, Muñoz-García M, Molina-Ruano MD, Rojo-Atenza E, García-Marcos L, Morales E; NELA Study Group. Cytokine profiles in cord blood in relation to prenatal traffic-related air pollution: The NELA cohort. Pediatr Allergy Immunol. 2022 Feb;33(2):e13732. doi: 10.1111/pai.13732. PubMed PMID: 35212052.
AÑO: 2022; IF: 4.4

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R